Gladius Capital Management LP Grows Stake in Iradimed Corporation (NASDAQ:IRMD)

Gladius Capital Management LP grew its stake in shares of Iradimed Corporation (NASDAQ:IRMD) by 126.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,727 shares of the medical equipment provider’s stock after purchasing an additional 965 shares during the quarter. Gladius Capital Management LP’s holdings in Iradimed were worth $87,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the stock. Mirae Asset Global Investments Co. Ltd. acquired a new position in Iradimed during the 1st quarter worth approximately $476,000. BNP Paribas Financial Markets boosted its stake in shares of Iradimed by 139.3% in the first quarter. BNP Paribas Financial Markets now owns 17,088 shares of the medical equipment provider’s stock valued at $752,000 after purchasing an additional 9,948 shares during the period. Swiss National Bank grew its holdings in Iradimed by 8.7% during the 1st quarter. Swiss National Bank now owns 16,200 shares of the medical equipment provider’s stock valued at $713,000 after purchasing an additional 1,300 shares in the last quarter. Roubaix Capital LLC purchased a new stake in Iradimed during the 1st quarter worth $2,213,000. Finally, Bessemer Group Inc. acquired a new position in Iradimed in the 1st quarter worth $183,000. Hedge funds and other institutional investors own 92.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm dropped their target price on Iradimed from $65.00 to $60.00 and set a “buy” rating on the stock in a research report on Friday, August 2nd.

Iradimed Trading Down 3.6 %

Iradimed stock opened at $51.99 on Friday. Iradimed Corporation has a 52 week low of $40.05 and a 52 week high of $57.95. The stock has a market cap of $658.71 million, a P/E ratio of 35.61 and a beta of 0.79. The stock has a 50 day moving average of $50.60 and a 200-day moving average of $46.49.

Iradimed Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 25th. Shareholders of record on Friday, November 15th will be paid a dividend of $0.15 per share. The ex-dividend date of this dividend is Friday, November 15th. This represents a $0.60 dividend on an annualized basis and a yield of 1.15%. Iradimed’s dividend payout ratio (DPR) is 41.10%.

Iradimed Company Profile

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device.